BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30985701)

  • 1. Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease.
    Mechie NC; Mavropoulou E; Ellenrieder V; Petzold G; Kunsch S; Neesse A; Amanzada A
    Medicine (Baltimore); 2019 Apr; 98(15):e15172. PubMed ID: 30985701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics.
    Valvano M; Magistroni M; Mancusi A; D'Ascenzo D; Longo S; Stefanelli G; Vernia F; Viscido A; Necozione S; Latella G
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.
    Hlavaty T; Krajcovicova A; Koller T; Toth J; Nevidanska M; Huorka M; Payer J
    World J Gastroenterol; 2014 Nov; 20(42):15787-96. PubMed ID: 25400464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin D status in inflammatory bowel disease.
    Veit LE; Maranda L; Fong J; Nwosu BU
    PLoS One; 2014; 9(7):e101583. PubMed ID: 24992465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)?
    Huang J; Chen T; Liu Y; Lyu L; Li X; Yue W
    Turk J Gastroenterol; 2019 Feb; 30(2):132-138. PubMed ID: 30429108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
    Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
    J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease.
    Han YM; Yoon H; Lim S; Sung MK; Shin CM; Park YS; Kim N; Lee DH; Kim JS
    Gut Liver; 2017 May; 11(3):363-369. PubMed ID: 28208007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
    Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
    Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.
    Ananthakrishnan AN; Khalili H; Higuchi LM; Bao Y; Korzenik JR; Giovannucci EL; Richter JM; Fuchs CS; Chan AT
    Gastroenterology; 2012 Mar; 142(3):482-9. PubMed ID: 22155183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cai T; Cheng SC; Savova G; Chen P; Szolovits P; Xia Z; De Jager PL; Shaw SY; Churchill S; Karlson EW; Kohane I; Plenge RM; Murphy SN; Liao KP
    Inflamm Bowel Dis; 2013 Aug; 19(9):1921-7. PubMed ID: 23751398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.
    López-Muñoz P; Beltrán B; Sáez-González E; Alba A; Nos P; Iborra M
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Ham NS; Hwang SW; Oh EH; Kim J; Lee HS; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
    Dig Dis Sci; 2021 Feb; 66(2):587-596. PubMed ID: 32219610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Association of Serum Vitamin D Concentration with Disease Activity and Trough Levels of Infliximab and Adalimumab during Inflammatory Bowel Disease Treatment.
    Mechie NC; Mavropoulou E; Ellenrieder V; Kunsch S; Cameron S; Amanzada A
    Digestion; 2020; 101(6):761-770. PubMed ID: 31536991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.
    Abreu MT; Kantorovich V; Vasiliauskas EA; Gruntmanis U; Matuk R; Daigle K; Chen S; Zehnder D; Lin YC; Yang H; Hewison M; Adams JS
    Gut; 2004 Aug; 53(8):1129-36. PubMed ID: 15247180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors are associated with vitamin D levels in IBD patients: A retrospective analysis.
    Schäffler H; Schmidt M; Huth A; Reiner J; Glass Ä; Lamprecht G
    J Dig Dis; 2018 Jan; 19(1):24-32. PubMed ID: 29232067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases.
    Gioxari A; Amerikanou C; Papada E; Zioga E; Georgoulis AD; Bamias G; Kaliora AC
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.
    Fang W; Kenny R; Rizvi QU; McMahon LP; Garg M
    BMC Gastroenterol; 2020 Jun; 20(1):183. PubMed ID: 32522150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease.
    Garg M; Rosella O; Lubel JS; Gibson PR
    Inflamm Bowel Dis; 2013 Nov; 19(12):2634-43. PubMed ID: 24105392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.